World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move ... 30/05/2025 SANOFI Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple... AseBio - SANOFI
Detecting the Undetectable: How Altum Sequencing Is Transforming Acute Myeloid Leukemia Mo... 29/05/2025 Healthcare Personalized medicine We demonstrated that our assay could detect residual disease in AML patients after treatment with 92% sensitivity and 88... Partners - Altum Sequencing
Accelerating molecular discovery using an in silico design platform 29/05/2025 Healthcare Schrödinger will host a scientific workshop in Barcelona on July 8 to showcase how its molecular design platform... Partners
Bioga and five Galician biotech companies to attend Swiss Biotech Day 2025 to network and ... 28/05/2025 Healthcare International Bioga and five Galician biotech companies joined Swiss Biotech Day 2025, one of Europe’s leading life sciences events... Partners - BIOGA
BCN HEALTH will present two communications at the Jornadas AES in June in Madrid 28/05/2025 Healthcare Financing BCN HEALTH will participate in the Jornadas de la Asociación de Economía de la Salud (AES), which will take place in... Partners - BCN Health
Natac strengthens its Branded Ingredients catalogue with the launch of Oligut 27/05/2025 Healthcare New patented product combines olive tree polyphenols and triterpenes to provide chronic inflammation control and improve... Partners - Natac Group
Sodena leads BioSintNA, the Synthetic Biology Business Plan in Navarra 27/05/2025 Healthcare Access to innovation Navarre takes a strategic step toward the future with the launch of BioSintNA, an ambitious synthetic biology business... Partners - SODENA
An Innovative App developed at San Cecilio Clinical Hospital with Support from ibs.GRANADA... 26/05/2025 Healthcare Manos Seguras 3.0, designed in collaboration with a Granada-based startup and supported by ibs.GRANADA, boosts the... Partners - FIBAO
aptaTargets transferred ApTOLL to Merck 26/05/2025 Healthcare Access to innovation Financing ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck to assume clinical... Partners - AptaTargets
Korea-EU Horizon Europe Researchers Networking Forum on Advanced Biotechnology Brussels Belgium Del 01/07/2025 to 03/07/2025 Healthcare
